Jamia Hamdard gets centre of excellence in Unani Medicine

Published On 2022-03-27 03:45 GMT   |   Update On 2022-03-27 03:46 GMT

New Delhi: The Ministry of Ayush has sanctioned Rs 10 crore for three years for establishing a centre of excellence in Unani medicine at the Jamia Hamdard here that will carry out advanced research, a statement from the university said on Thursday.The project involves the development of a research centre having advanced facilities for drug testing and quality control, including training of...

Login or Register to read the full article

New Delhi: The Ministry of Ayush has sanctioned Rs 10 crore for three years for establishing a centre of excellence in Unani medicine at the Jamia Hamdard here that will carry out advanced research, a statement from the university said on Thursday.

The project involves the development of a research centre having advanced facilities for drug testing and quality control, including training of Unani professionals, organising of international conferences and generation of data for scientific validation, monograph development, modernisation of dosage forms as well as IPR generation for new products, it added.

Also Read:Hamdard Labs enters OTX segment, launches 13 new products 

"In recognition of high-quality research on Unani Medicine at Jamia Hamdard, Ministry of AYUSH have granted approval of a Centre of Excellence in Unani Medicine for advanced research on Pharmacognosy and Pharmacology of Pharmacopoeial Drugs of Unani Medicine under Ayurswastha Yojana of Ministry of Ayush, and sanctioned Rs 10 crore for three years," said the statement.

The Vice-Chancellor of Jamia Hamdard, M Afshar Alam, thanked the Central Council for Research in Unani Medicine and the Ayush ministry for granting the project.

Medical Dialogues team had recently published that The Ayush Ministry has initiated the world's first multicentre phase-3 clinical trial to examine the efficacy of Ayurveda in the treatment of rheumatoid arthritis, according to an official statement.

The clinical trial will be conducted following the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Good Clinical Practice guidelines, it stated.

It will be closely monitored by Dr. Daniel Erick Furst, a renowned rheumatologist at the University of California, the statement mentioned. 

This project is one of the first multi-center phase-3 double-blind double-dummy clinical trials on the efficacy of Ayurveda in the management of rheumatoid arthritis, it claimed.

The trial will be conducted by AVP Research Foundation, affiliated with the Arya Vaidya Pharmacy (Coimbatore) Ltd and the Central Council for Research in Ayurveda, an agency under the Ayush Ministry. 

Also Read:Now Ayurveda, Siddha, Unani practitioners can issue medical fitness certificates

Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News